Patented Drugmaker Investment To Remain Muted In Croatia
Pharma & Healthcare / Croatia / Mon 09 Jul, 2018
Key View:
- Opportunities for patented drugmakers will be limited by healthcare funding issues.
- Most major multinational drugmakers are present in the market but activity is limited to clinical trials and marketing.
- Investment by innovative pharmaceutical firms will remain concentrated in Western Europe.
Forecasts:
We forecast patented